Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Placenta-Based Cell Therapy
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +22.65% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +22.65% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 52 | 06-10-31 |
Director of Finance/CFO | 40 | 13-04-30 | |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Artur Machlenkin
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Nitsan Halevy
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Lior Raviv
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
Orly Amiran
PRN | Corporate Officer/Principal | - | - |
Nimrod Bar Zvi
PRN | Corporate Officer/Principal | - | - |
Efrat Kaduri
PRN | Corporate Officer/Principal | - | 14-09-30 |
Human Resources Officer | 62 | 06-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 21-07-14 | |
Lorne Abony
BRD | Director/Board Member | 55 | 23-07-10 |
Zami Aberman
CHM | Chairman | 70 | 05-09-25 |
Yaky Yanay
CEO | Chief Executive Officer | 52 | 06-10-31 |
Director/Board Member | 54 | 21-01-05 | |
Director/Board Member | 61 | 21-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,227,120 | 3,940,262 ( 75.38 %) | 0 | 75.38 % |
Company contact information
Pluri, Inc.
MATAM Advanced Technology Park Building No. 5
3508409, Haifa
+972 74 710 8600
http://www.pluri-biotech.comSector
1st Jan change | Capi. | |
---|---|---|
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.81% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |